The development of cannabinoid receptor type 2 (CB2R) PET radioligands has been
intensively explored due to the pronounced CB2R upregulation under various pathological …

The cannabinoid receptor type 2 (CB2R) is an attractive target for the diagnosis and therapy
of neurodegenerative diseases and cancer. In this study, we aimed at the development of a …

Background The level of expression of cannabinoid receptor type 2 (CB 2 R) in healthy and
diseased brain has not been fully elucidated. Therefore, there is a growing interest to assess …

Cannabinoid receptors type 2 (CB2R) represent an attractive therapeutic target for
neurodegenerative diseases and cancer. Aiming at the development of a positron emission …

Cannabinoids have been recently proposed as a new family of potential antitumor agents,
and cannabinoid receptor 2 (CB2) is believed to be over-expressed in tumor cells. This …

Despite the broad implications of the cannabinoid type 2 receptor (CB2) in
neuroinflammatory processes, a suitable CB2-targeted probe is currently lacking in clinical …

Cannabinoid receptor 1 (CB1R) controls various physiological and pathological conditions,
including memory, motivation, and inflammation, and is thus an interesting target for positron …

1048 Objectives CB2R represents a target with increasing importance for neuroimaging due
to its upregulation in various pathological conditions. Encouraged by preliminary results …

Cannabinoid receptors type 2 (CB2) represent a target with increasing importance for
neuroimaging due to its upregulation under various pathological conditions. Encouraged by …

The type 2 cannabinoid receptor (CB2R) is part of the endocannabinoid system and is
expressed in tissues related to the immune system. As the CB2R has a very low brain …